Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > I'd much rather be ignorant...
View:
Post by ragingbull1327 on May 06, 2015 9:40am

I'd much rather be ignorant...

Than to be incredibly educated and unable to cure cancer in 2015
Comment by ragingbull1327 on May 06, 2015 9:44am
These people can't even make their own stock price appreciate 1997 prices.   Well done.   That's an incredible amount of time that you and your MULTI BILLION PARTNER have wasted.   No wonder they haven't cured cancer.    Somehow Endo is a gorilla, and Valeant is a GIANT.    NEITHER can cure anything BUT they can sure kill a decade. 
Comment by burritscold on May 06, 2015 10:28am
I believe your wish was granted long ago!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities